Bone biopsy of new suspicious bone lesions in patients with primary carcinoma: Prevalence and probability of an alternative diagnosis

American Journal of Roentgenology

Volumn 193, Issue 5, 2009, Pages

  Cronin, Carmel G ^a   Cashell, Thomas ^a   Mhuircheartaigh, Jennifer Ni ^a   Swords, Ronan ^a   Murray, Margaret ^a   O'Sullivan, Gerard J ^a   O'Keeffe, David ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Bone biopsy; Cancer; CT guided biopsy; Metastasis; Suspicious bone lesion

Indexed keywords

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE CANCER; BONE LESION; BONE RADIOGRAPHY; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; FEMALE; FRACTURE; GASTROINTESTINAL TRACT; HUMAN; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; METASTASIS; MYELOFIBROSIS; MYELOMA; PREVALENCE; PRIORITY JOURNAL; SACRUM; THYROID CANCER; TREATMENT INDICATION; UROGENITAL SYSTEM; UROGENITAL TRACT CANCER;

AGED; BIOPSY; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PREVALENCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70449511787     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1882     Document Type: Article

References (11)

1. Espinosa LA, Jamadar DA, Jacobson JA, et al. CTguided biopsy of bone: a radiologist's perspective. AJR 2008; 190:1270; [web]W283-W289
2. DeSantos LA, Lukeman JM, Wallace S, Murray JA, Ayala AG. Percutaneous needle biopsy of bone in the cancer patient. AJR 1978; 130:641-649 (Pubitemid 8324815)
3. Krause ND, Haddad ZK, Winalski CS, Ready JE, Nawfel RD, Carrino JA. Musculoskeletal biopsies using computed tomography fluoroscopy. J Comput Assist Tomogr 2008; 32:458-462
4. Rimondi E, Staals EL, Errani C, et al. Percutaneous CT-guided biopsy of the spine: results of 430 biopsies. Eur Spine J 2008; 17:975-981
5. Leffler SG, Chew FS. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic yield and accuracy. AJR 1999; 172:1389-1392
6. Masood S, Bui MM. Assessment of HER-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study. Ann Clin Lab Sci 2000; 30:259-265 (Pubitemid 30620800)
7. Gancberg D, Di Leo A, Cardoso F, et al. Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Ann Oncol 2002; 13:1036-1043 (Pubitemid 34885003)
8. Tanner M, Järvinen P, Isola J. Amplification of HER-2/neu and topoisomerase II alpha in primary and metastatic breast cancer. Cancer Res 2001;61:5345-5348 (Pubitemid 32694907)
9. Matsubara H, Yamada Y, Naruse K, et al. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization. Oncol Rep 2008; 19:57-63 (Pubitemid 351176131)
10. Tuefferd M, Couturier J, Penault-Llorca F, et al. HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients. PLoS One 2007;2:e1138 (Pubitemid 351597374)
11. Reichelt U, Duesedau P, Tsourlakis MCh, et al. Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus. Mod Pathol 2007; 20:120-129 (Pubitemid 44967957)